This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jul 1;43(1):103-5.

doi: 10.1086/504878. Epub 2006 May 26.

Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?

Elizabeth J Phillips

PMID: 16758425
DOI: 10.1086/504878

Editorial

Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?

Elizabeth J Phillips. Clin Infect Dis. 2006.

. 2006 Jul 1;43(1):103-5.

doi: 10.1086/504878. Epub 2006 May 26.

Author

Elizabeth J Phillips

PMID: 16758425
DOI: 10.1086/504878

No abstract available

PubMed Disclaimer

Comment on

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S. Rauch A, et al. Clin Infect Dis. 2006 Jul 1;43(1):99-102. doi: 10.1086/504874. Epub 2006 May 26. Clin Infect Dis. 2006. PMID: 16758424

Similar articles

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.
Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S. Rauch A, et al. Clin Infect Dis. 2006 Jul 1;43(1):99-102. doi: 10.1086/504874. Epub 2006 May 26. Clin Infect Dis. 2006. PMID: 16758424
Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
Guo Y, Shi L, Hong H, Su Z, Fuscoe J, Ning B. Guo Y, et al. Sci China Life Sci. 2013 Feb;56(2):119-24. doi: 10.1007/s11427-013-4438-8. Epub 2013 Feb 8. Sci China Life Sci. 2013. PMID: 23393027 Review.
HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
Lucas A, Nolan D, Mallal S. Lucas A, et al. J Antimicrob Chemother. 2007 Apr;59(4):591-3. doi: 10.1093/jac/dkl557. Epub 2007 Feb 22. J Antimicrob Chemother. 2007. PMID: 17317695
[HLA-B*5701 and abacavir hypersensitivity reaction].
Servonnet A, Leclercq E, Delacour H, Ceppa F. Servonnet A, et al. Pathol Biol (Paris). 2010 Dec;58(6):e95-100. doi: 10.1016/j.patbio.2008.12.001. Epub 2009 Feb 24. Pathol Biol (Paris). 2010. PMID: 19243901 French.
HLA alleles and drug hypersensitivity reactions.
Profaizer T, Eckels D. Profaizer T, et al. Int J Immunogenet. 2012 Apr;39(2):99-105. doi: 10.1111/j.1744-313X.2011.01061.x. Epub 2011 Dec 3. Int J Immunogenet. 2012. PMID: 22136512 Review.

See all similar articles

Cited by

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.
Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE. Schackman BR, et al. AIDS. 2008 Oct 1;22(15):2025-33. doi: 10.1097/QAD.0b013e3283103ce6. AIDS. 2008. PMID: 18784465 Free PMC article.
Clinical Abacavir Hypersensitivity Reaction among Children in India.
Chakravarty J, Sharma S, Johri A, Chourasia A, Sundar S. Chakravarty J, et al. Indian J Pediatr. 2016 Aug;83(8):855-8. doi: 10.1007/s12098-016-2044-z. Epub 2016 Feb 18. Indian J Pediatr. 2016. PMID: 26887762
The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand.
Bushyakanist A, Puangpetch A, Sukasem C, Kiertiburanakul S. Bushyakanist A, et al. Pharmgenomics Pers Med. 2015 Nov 5;8:163-70. doi: 10.2147/PGPM.S86444. eCollection 2015. Pharmgenomics Pers Med. 2015. PMID: 26604812 Free PMC article.
Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients.
Baniasadi S, Shokouhi SB, Tabarsi P, Alehashem M, Khalili H, Fahimi F, Nadji SA. Baniasadi S, et al. Tanaffos. 2016;15(1):48-52. Tanaffos. 2016. PMID: 27403179 Free PMC article.
Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.
Ann H, Kim KH, Choi HY, Chang HH, Han SH, Kim KH, Lee JS, Kim YS, Park KH, Kim YK, Sohn JW, Yun NR, Lee CS, Choi YW, Lee YS, Kim SW. Ann H, et al. Infect Chemother. 2017 Sep;49(3):205-212. doi: 10.3947/ic.2017.49.3.205. Infect Chemother. 2017. PMID: 29027387 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information